WithdrawnNCT02333149
Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population
Placebo comparisonAges 6–17Canada
Understand this study
Who could participate?
Listed age limits: 6 years to 17 years.
- Listed locations
- EdmontonSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 1, 2019
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- University of Alberta
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Dietary supplement, Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Canada
- Age range
- From 6 Years to 17 Years
- Official registry ID
- NCT02333149
- Official title
Show the full official title
Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Edmonton
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Alberta, a university.
Does this study involve medication?
Yes. The study involves medication, including Placebo.
Who can participate?
Listed age limits: 6 years to 17 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
